Abstract
The study aimed to assess the role of CD151-integrin α3β1 (INGA3) complex as a potential prognostic indicator in OSCC and to examine whether mapping of its expression in the invasive front separately from that in the rest of the tumour would have an impact on the predictive value of the results. CD151/INGA3 profiles were compared with that of EGFR.
Original language | English |
---|---|
Pages (from-to) | 224-9 |
Number of pages | 6 |
Journal | Oral Oncology |
Volume | 49 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2013 |
Bibliographical note
Copyright © 2012 Elsevier Ltd. All rights reserved.Keywords
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antigens, CD151
- Carcinoma, Squamous Cell
- Cohort Studies
- Disease-Free Survival
- Epithelium
- Female
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Integrin alpha3
- Integrin alpha3beta1
- Lymph Nodes
- Male
- Middle Aged
- Mouth Mucosa
- Mouth Neoplasms
- Neoplasm Grading
- Neoplasm Invasiveness
- Neoplasm Staging
- Predictive Value of Tests
- Prognosis
- Receptor, Epidermal Growth Factor
- Tumor Markers, Biological
- Young Adult